Therapeutic Implications of PPARγ in Cardiovascular Diseases

Tesse, A., Andriantsitohaina, R., & Ragot, T. (2009). PPARδ Activity in Cardiovascular Diseases: A Potential Pharmacological Target. PPAR Research, 2009(), 271-279. https://doi.org/10.1155/2009/745821
Chandra, M., Miriyala, S., & Panchatcharam, M. (2017). PPARγ and Its Role in Cardiovascular Diseases. PPAR Research, 2017(), 1-10-016. https://doi.org/10.1155/2017/6404638
Calvert, J. W., Kevil, C. G., & Spite, M. R. (2012). Regulation and Maintenance of Vascular Tone and Patency in Cardiovascular Health and Disease. International Journal of Vascular Medicine, 2012(), 116-117. https://doi.org/10.1155/2012/396369
Finck, B. N., Chinetti, G., & Staels, B. (2008). PPARs/RXRs in Cardiovascular Physiology and Disease. PPAR Research, 2008(), 169-169-014. https://doi.org/10.1155/2008/173780
Lee, Y. H., Lin, P. L., Chiou, W. R., Liao, F. C., Chang, S. H., Kuo, J. Y., & Hou, C. J. Y. (2017). Non-pharmacologic Management of Structural Heart Disease. 內科學誌, 28(4), 218-222. https://doi.org/10.6314/JIMT.2017.28(4).04